tirzepatide legal battle Compounders lose over Eli Lilly weight loss drug and FDA shortage list Tirzepatide compounded: Can you still

Eli Lilly $LLY announced today that the drug behind Zepbound was found to help alleviate sleep apnea in patients with obesity in late-stage clinical trials

If your plan doesnt cover Zepbound or you pay cash for your prescriptions, you may still be able to save on the cost of Zepbound with a pharmacy discount card

It is not FDA-approved for any use and is not available for prescription

Kidney Problems: GLP-1 medications can sometimes affect kidney function, especially in people with pre-existing kidney disease

It's the compound with robust Phase 3 evidence for weight reduction (20.9% mean body weight loss at 72 weeks in the SURMOUNT-1 trial)